| Nov 7 |
Moderna Stock Rises on Surprise Q3 Profit
|
| Nov 7 |
Moderna Gets Third-Quarter Boost From Early COVID-19 Shot Approval as Sales Top Street Views
|
| Nov 7 |
2025 will be 'fairly challenging year' for Moderna: Analyst
|
| Nov 7 |
Ahead of Fed Decision, Big Earnings Wins for Forgotten Names
|
| Nov 7 |
Moderna Sales Get Lift From Early Nod for Newest Covid Shot
|
| Nov 7 |
Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook
|
| Nov 7 |
Moderna Stock Jumps on Better-Than-Expected Covid-19 Vaccine Sales
|
| Nov 7 |
Moderna, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 7 |
Moderna swings to profits as new COVID shot powers Q3 beat
|
| Nov 7 |
Moderna (MRNA) Q3 Earnings and Revenues Surpass Estimates
|
